[ad_1]
“I really do not think that we are already at the stage where we can vaccinate everyone who comes in and wants to, because there are still many people at risk who have not been vaccinated, among whom there is no doubt that those who would also like to be vaccinated with AstraZeneca, but we can expect some flexibility in the use of this vaccine, ”he emphasized when asked if the AstraZeneca vaccine was not considered as an option in the future.
According to the Prime Minister, the decision to suspend vaccination with AstraZeneca will be valid until the EVA has ruled on this vaccine.
According to I. Šimonytė, the SAM’s decision to stop vaccination was natural when such a recommendation from the State Agency for Drug Control (VVKT) appeared.
“Until the decision is made, the government has received the same criticism for not making this decision,” the Prime Minister said after the government meeting on Health Minister Arūnas Dulkis’s decision to temporarily suspend vaccination with AstraZeneca.
According to her, until the IWT presentation, which was presented on Tuesday night, she was convinced that there was no basis for such a decision.
And now I think that tomorrow the European Medicines Agency is likely to repeat what it has said more than once that it cannot establish any causal link between some health problems and even deaths and vaccination. “AstraZeneca” vaccine or any other registered vaccine, “he said.
I. Šimonytė emphasized that he still believes that vaccination is the main strategy to overcome the coronavirus crisis, and at the same time emphasized that AstraZeneca’s reputational problem is not something new, it is a vaccine that tends to accumulate.
“There are certain beliefs that are difficult to disprove, even if scientists deny them … sometimes people make decisions based on other beliefs,” he emphasized.
However, I. Šimonytė admitted that A. Dulkis’ decision does not help the vaccination process, just as the discussions that arose about this vaccine did not help him.
According to the Prime Minister, he would blame AstraZeneca more for the breach of supply obligations than for the quality of the product.
The list of municipalities with restricted circulation is subject to change.
When asked on Wednesday if it was not planned to review the list of municipalities where movement restrictions were left in the future, I. Šimonytė did not rule out that it could change. However, only if the epidemiological situation in the municipalities changes.
It is not the case that the list is “loaded” until April, until May, or even before any month. “The ruling is now valid until March 31, and we may review those restrictions next week, and there may be no reason to review them,” he said.
[ad_2]
